Cargando…
Role of Functional Neuroimaging with 123I-MIBG and 123I-FP-CIT in De Novo Parkinson’s Disease: A Multicenter Study
Background: Parkinson’s disease is a progressive neurodegenerative disorder, with incidence and prevalence rates of 8–18 per 100,000 people per year and 0.3–1%, respectively. As parkinsonian symptoms do not appear until approximately 50–60% of the nigral DA-releasing neurons have been lost, the impa...
Autores principales: | De Feo, Maria Silvia, Frantellizzi, Viviana, Locuratolo, Nicoletta, Di Rocco, Arianna, Farcomeni, Alessio, Pauletti, Caterina, Marongiu, Andrea, Lazri, Julia, Nuvoli, Susanna, Fattapposta, Francesco, De Vincentis, Giuseppe, Spanu, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455638/ https://www.ncbi.nlm.nih.gov/pubmed/37629643 http://dx.doi.org/10.3390/life13081786 |
Ejemplares similares
-
The prognostic value of (123)I-mIBG SPECT cardiac imaging in heart failure patients: a systematic review
por: Pontico, Mariano, et al.
Publicado: (2021) -
Autopsy validation of (123)I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB
por: Thomas, Alan J., et al.
Publicado: (2017) -
Clinicopathological and (123)I‐FP‐CIT SPECT correlations in patients with dementia
por: Jung, Youngsin, et al.
Publicado: (2018) -
(123)I-ioflupane brain SPECT and (123)I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders
por: Nuvoli, Susanna, et al.
Publicado: (2017) -
The utility of the combination of a SPECT study with [(123)I]-FP-CIT of dopamine transporters and [(123)I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes
por: Uyama, Naoto, et al.
Publicado: (2017)